CEFALY Technology Launches Outreach and Education Initiative to Explore the Connection Between Migraine and Depression

DARIEN, Conn., May 23, 2024 /PRNewswire/ -- CEFALY Technology, maker of the innovative CEFALY migraine treatment device, is launching a new education campaign to help people understand the migraine-depression link.

Migraine is a complex neurological disorder that is commonly characterized by episodes of intense headache pain plus other symptoms, such as nausea, vomiting, and sensitivity to light and sound. Depression is a serious mental disorder marked by persistent feelings of sadness, irritability, hopelessness, fatigue, and other symptoms. 

The migraine-depression connection is bidirectional; having one condition gives you a higher risk of also having the other. According to the Anxiety & Depression Association of America, If you have depression, you are 3.4 times more likely to develop migraine. If you live with migraine, you are 5.8 times more likely to develop depression. 

CEFALY is hosting a free webinar May 28, 2024, at 12 p.m. ET, in which licensed professional counselor Cara Scruggs will discuss the many links between migraine and depression. She will also review the wide range of treatment options for depression and migraine. Scruggs is a patient advocate, clinical consultant, and public speaker who has honed her clinical expertise through mental health work in school systems, inpatient hospitals, outpatient services, and private practice. 

Register to attend the webinar here. 

"Migraine and clinical depression are both common conditions, yet many people who live with both feel isolated and disconnected," said Jen Trainor-McDermott, CEO of CEFALY Technology. "As part of our CEFALY Cares initiative, we're reaching out to those people to tell them that they're not alone. We're here to support their treatment journey, so they can feel better and get back to life."

About the CEFALY device:

CEFALY Technology is the maker of CEFALY, an FDA-cleared, over-the-counter wearable medical device clinically proven to help reduce migraine frequency and relieve migraine pain. CEFALY is a non-invasive device placed on the forehead to modify pain sensation in the area research identifies as a center for migraine pain, the trigeminal nerve. 

The Bluetooth-enabled CEFALY Connected syncs with the CeCe Migraine Management app and enables users to track CEFALY treatments and log migraine attacks on their mobile device. With these insights, they can better understand their migraine patterns and optimize their treatments.

About CEFALY Technology:

CEFALY Technology is a Belgium-based company with U.S. offices based in Darien, Conn., specializing in electronics for medical applications. For 20 years, CEFALY Technology has provided innovative, ever-evolving technology that enables people with migraine to take control of their treatment and live happier, healthier lives.

Learn more about CEFALY by visiting www.CEFALY.com and following us on Facebook, Twitter, LinkedIn, Instagram and TikTok.

Media Contact:
CEFALY
Jen Trainor McDermott
CEO
[email protected] 

SOURCE CEFALY Technology